-
Kazia Therapeutics Shares Are Jumping Today: Successful Study For Brain Cancer Treatment
Wednesday, July 10, 2024 - 12:24pm | 477Read More...Kazia Therapeutics Limited (NASDAQ:KZIA) released results on Wednesday from the GBM-AGILE Phase 2/3 study that included an evaluation of paxalisib versus standard of care (SOC) for patients with glioblastoma, a type of brain cancer. Shares are trading higher on a strong session volume of 106.49...
-
What's Up With Cassava Sciences Flying Today?
Tuesday, November 2, 2021 - 4:28pm | 419Read More...Cassava Sciences Inc (NASDAQ: SAVA) shares are trading up Tuesday as traders were able to push the stock higher. The stock has been trending on social media sites such as StockTwits throughout the day. Cassava Sciences is trading up 25.94% at $58.07 Tuesday at market close. Cassava...
-
Amgen, Neumora Collaborate On Precision Therapies for Brain Diseases
Thursday, October 7, 2021 - 7:27am | 190Read More...Amgen Inc (NASDAQ: AMGN) and Neumora Therapeutics Inc have announced a strategic collaboration to advance neuroscience discovery, development, and commercialization. The companies will collaborate on programs by applying Neumora's proprietary precision neuroscience...
-
FSD Pharma To Buy Canadian Psychedelic Pharmaceutical Firm
Wednesday, August 25, 2021 - 1:41pm | 222Read More...FSD Pharma Inc (NASDAQ: HUGE) shares rebounded after falling in premarket on acquiring a Canada-based psychedelic pharmaceutical company. Related: See Why FSD Pharma Terminated COVID-19 Trial FSD Pharma has agreed to acquire Lucid Psycheceuticals Inc for approximately $9...
-
Will Brain Science Ever Explain Why Traders Make $2 Billion Mistakes?
Friday, May 18, 2012 - 6:15pm | 1987Read More...By Sarah Churchville, Minyanville People may behave unreasonably and even self-destructively in other arenas, but when it comes to the market, clinical rationality wins the day, right? Well, we all know better than that. In fact, one of the main difficulties in using game theory to model market...
